Stem Cells on the Brain: Modeling Neurodevelopmental and Neurodegenerative Diseases Using Human Induced Pluripotent Stem Cells
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Seven years have passed since the initial report of the generation of induced pluripotent stem cells (iPSCs) from adult human somatic cells, and in the intervening time the field of neuroscience has developed numerous disease models using this technology. Here, we review progress in the field and describe both the advantages and potential pitfalls of modeling neurodegenerative and neurodevelopmental diseases using this technology. We include tables with information on neural differentiation protocols and studies that developed human iPSC lines to model neurological diseases. We also discuss how one can: investigate effects of genetic mutations with iPSCs, examine cell fate-specific phenotypes, best determine the specificity of a phenotype, and bring in vivo relevance to this in vitro technique.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cerebral organoids model human brain development and microcephaly
Lancaster, M. A., Renner, M., Martin, C.-A., Wenzel, D., Bicknell, L. S., Hurles, M. E., Homfray, T., Penninger, J. M., Jackson, A. P., & Knoblich, J. A. (2013) · Nature · doi:10.1038/nature12517 · Cited by 5,372 · cited 3×
“…proliferation, neuronal migration, and neurite outgrowth and arborization (Dhara & Stice, 2008; Eiraku et al., 2008; Gaspard et al., 2008; Krencik & Zhang, 2006; Lancaster et al., 2013; H. Liu & Zhang, 2011; Mariani et al., 2012; Maroof et al., 2013; Nicholas et al., 2013; Watanabe et al., 2005).”
BackgroundEpidemiology of Parkinson's disease
de Lau, L. M., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70471-9 · Cited by 4,110 · cited 1×
“…average ~ 40 years [Myers, 2004; Walker, 2007], ALS: average ~ 60 years [Chi ò et al., 2013; Huisman et al., 2011]; Parkinson ’ s disease: 60 years [de Lau & Breteler, 2006]; Alzheimer ’ s disease: 65 years [Thies, Bleiler, Alzheimer ’ s Association, 2013]), calling into question whether…”
ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering
Gaj, T., Gersbach, C. A., & Barbas, C. F. (2013) · Trends in Biotechnology · doi:10.1016/j.tibtech.2013.04.004 · Cited by 3,820
Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling
Chambers, S. M., Fasano, C. A., Papapetrou, E. P., Tomishima, M., Sadelain, M., & Studer, L. (2009) · Nature Biotechnology · doi:10.1038/nbt.1529 · Cited by 3,620 · cited 4×
“…Lee et al., 2007b; X.-J. Li et al., 2005; 2008; Nizzardo et al., 2010; Roy et al., 2005; Wada et al., 2009; Zeng et al., 2010 Dopaminergic neurons Chambers et al., 2009; Cho et al., 2008a; Cho et al., 2008b; Cooper et al., 2010; Elkabetz et al., 2008; Erceg et al., 2008; Iacovitti et al., 2007;…”
BackgroundMethodInfluentialDouble nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity
Ran, F. A., Hsu, P. D., Lin, C.-Y., Gootenberg, J. S., Konermann, S., Trevino, A. E., Scott, D. A., Inoue, A., Matoba, S., Zhang, Y., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.021 · Cited by 3,299 · cited 1×
“…2012b 2013 2 LRRK2 G2019S with gene correction, 4 wt Dopaminergic neurons Neurite outgrowth, cell death in response to certain toxins, tau and α - synuclein expression Reinhardt et al., 2013 2013 1 LRRK2 homo G2019S, 1 wt Dopaminergic neurons Mitochondrial morphology, ATP levels, mitochondrial…”
BackgroundHigh-Frequency off-Target Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells
Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2623 · Cited by 3,292 · cited 1×
“…CRISPR-Cas system (an RNA-guided nuclease) demonstrates higher genome editing effi ciency than TALENs (Q. Ding, Regan, et al., 2013b), but also has increased potential for initiating off-target cleavage events (Fu et al., 2013; Hsu et al., 2013; Mali, Aach, et al., 2013a; Pattanayak et al., 2013).”
BackgroundGenome editing with engineered zinc finger nucleases
Urnov, F. D., Rebar, E. J., Holmes, M. C., Zhang, H. S., & Gregory, P. D. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2842 · Cited by 2,285
Apolipoprotein E: Far More Than a Lipid Transport Protein
Mahley, R. W., & Rall, S. C. (2000) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.1.1.507 · Cited by 1,836
Insel, T. R. (2010) · Nature · doi:10.1038/nature09552 · Cited by 1,783
Mali, P., Aach, J., Stranges, P. B., Esvelt, K. M., Moosburner, M., Kosuri, S., Yang, L., & Church, G. M. (2013) · Nature Biotechnology · doi:10.1038/nbt.2675 · Cited by 1,752
Eiraku, M., Watanabe, K., Matsuo-Takasaki, M., Kawada, M., Yonemura, S., Matsumura, M., Wataya, T., Nishiyama, A., Muguruma, K., & Sasai, Y. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.09.002 · Cited by 1,522 · cited 2×
“Cell type References Forebrain neuronal precursors or neurons Chambers et al., 2009; Eiraku et al., 2008; Elkabetz et al., 2008; Emdad et al., 2012; Erceg et al., 2008; Espuny-Camacho et al., 2013; Gupta et al., 2011; Hu et al., 2010; Juopperi et al., 2012; Kirkeby et al., 2012; Lancaster et al.,…”
BackgroundPattanayak, V., Lin, S., Guilinger, J. P., Ma, E., Doudna, J. A., & Liu, D. R. (2013) · Nature Biotechnology · doi:10.1038/nbt.2673 · Cited by 1,487 · cited 1×
“…CRISPR-Cas system (an RNA-guided nuclease) demonstrates higher genome editing effi ciency than TALENs (Q. Ding, Regan, et al., 2013b), but also has increased potential for initiating off-target cleavage events (Fu et al., 2013; Hsu et al., 2013; Mali, Aach, et al., 2013a; Pattanayak et al., 2013).”
BackgroundSelf-formation of optic cups and storable stratified neural retina from human ESCs
Nakano, T., Ando, S., Takata, N., Kawada, M., Muguruma, K., Sekiguchi, K., Saito, K., Yonemura, S., Eiraku, M., & Sasai, Y. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.05.009 · Cited by 1,447 · cited 1×
“…placode derivatives Dincer et al., 2013 Retinal cells Buchholz et al., 2009; Hirami et al., 2009; Jin et al., 2011; Kokkinaki et al., 2011; Lamba et al., 2006; Meyer et al., 2009; 2011; Nakano et al., 2012; Osakada et al., 2008, 2009a., 2009b; Phillips et al., 2012; Tucker et al., 2011 Note.”
BackgroundNormal development of brain circuits
Tau, G. Z., & Peterson, B. S. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.115 · Cited by 1,391
Modelling schizophrenia using human induced pluripotent stem cells
Brennand, K. J., Simone, A., Jou, J., Gelboin-Burkhart, C., Tran, N., Sangar, S., Li, Y., Mu, Y., Chen, G., Yu, D., et al. (2011) · Nature · doi:10.1038/nature09915 · Cited by 1,375
Marchetto, M. C. N., Carromeu, C., Acab, A., Yu, D., Yeo, G. W., Mu, Y., Chen, G., Gage, F. H., & Muotri, A. R. (2010) · Cell · doi:10.1016/j.cell.2010.10.016 · Cited by 1,329
The Story of Rett Syndrome: From Clinic to Neurobiology
Chahrour, M., & Zoghbi, H. Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.10.001 · Cited by 1,265 · cited 1×
“…neurological diseases studied with iPSCs (fragile X syndrome: neonatal [Jacquemont et al., 2007]; Rett syndrome: 6 – 18 months [Amir et al., 1999; Chahrour & Zoghbi, 2007]; schizophrenia: 15 – 30 years [Stilo & Murray, 2010]; Huntington ’ s disease: average ~ 40 years [Myers, 2004; Walker,…”
Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells
Israel, M. A., Yuan, S. H., Bardy, C., Reyna, S. M., Mu, Y., Herrera, C., Hefferan, M. P., Van Gorp, S., Nazor, K. L., Boscolo, F. S., et al. (2012) · Nature · doi:10.1038/nature10821 · Cited by 1,253 · cited 1×
“…2 sporadic AD, 2 APP duplication, 1 wt Neurons, co-culture with astrocytes A β generation, Tau phosphorylation, GSK3 β phosphorylation, endosome size Israel et al., 2012 2013 1 APP homo E693 ∆ , 1 APP V717L, 2 sporadic AD, 3 wt Cortical neurons A β generation, localization, and…”
Schizophrenia as a Disorder of Neurodevelopment
Lewis, D. A., & Levitt, P. (2002) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.25.112701.142754 · Cited by 1,163
An improved zinc-finger nuclease architecture for highly specific genome editing
Miller, J. C., Holmes, M. C., Wang, J., Guschin, D. Y., Lee, Y.-L., Rupniewski, I., Beausejour, C. M., Waite, A. J., Wang, N. S., Kim, K. A., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1319 · Cited by 1,051 · cited 1×
“One proposed method to improve ZFN and TALEN specifi city is to use a mutated FokI nuclease, making it an obligate heterodimer (Doyon et al., 2010; Hockemeyer et al., 2011; P. Huang et al., 2011; J. C. Miller et al., 2007; Tesson et al., 2011; Wood et al., 2011).”
MethodBock, C., Kiskinis, E., Verstappen, G., Gu, H., Boulting, G., Smith, Z. D., Ziller, M., Croft, G. F., Amoroso, M. W., Oakley, D. H., et al. (2011) · Cell · doi:10.1016/j.cell.2010.12.032 · Cited by 1,009
RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention
Donnelly, C. J., Zhang, P.-W., Pham, J. T., Haeusler, A. R., Mistry, N. A., Vidensky, S., Daley, E. L., Poth, E. M., Hoover, B., Fines, D. M., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.015 · Cited by 877
Chiò, A., Logroscino, G., Traynor, B. J., Collins, J., Simeone, J. C., Goldstein, L. A., & White, L. A. (2013) · Neuroepidemiology · doi:10.1159/000351153 · Cited by 862
Apolipoprotein E in Alzheimer’s disease and other neurological disorders
Verghese, P. B., Castellano, J. M., & Holtzman, D. M. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70325-2 · Cited by 857
The Genetics of Alzheimer Disease: Back to the Future
Bertram, L., Lill, C. M., & Tanzi, R. E. (2010) · Neuron · doi:10.1016/j.neuron.2010.10.013 · Cited by 834
Human cerebral cortex development from pluripotent stem cells to functional excitatory synapses
Shi, Y., Kirwan, P., Smith, J., Robinson, H. P. C., & Livesey, F. J. (2012) · Nature Neuroscience · doi:10.1038/nn.3041 · Cited by 813
Non–cell autonomous effect of glia on motor neurons in an embryonic stem cell–based ALS model
Di Giorgio, F. P., Carrasco, M. A., Siao, M. C., Maniatis, T., & Eggan, K. (2007) · Nature Neuroscience · doi:10.1038/nn1885 · Cited by 799 · cited 1×
“Non-cell autonomous effects have been carefully studied in models of ALS, which have revealed cytotoxicity of SOD1 -mutant astrocytes on motor neurons (Di Giorgio et al., 2007, 2008; Marchetto et al., 2008).”
BackgroundHuman iPSC-based modeling of late-onset disease via progerin-induced aging
Miller, J. D., Ganat, Y. M., Kishinevsky, S., Bowman, R. L., Liu, B., Tu, E. Y., Mandal, P. K., Vera, E., Shim, J.-W., Kriks, S., et al. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.11.006 · Cited by 777
Kondo, T., Asai, M., Tsukita, K., Kutoku, Y., Ohsawa, Y., Sunada, Y., Imamura, K., Egawa, N., Yahata, N., Okita, K., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.01.009 · Cited by 741 · cited 1×
“…co-culture with astrocytes A β generation, Tau phosphorylation, GSK3 β phosphorylation, endosome size Israel et al., 2012 2013 1 APP homo E693 ∆ , 1 APP V717L, 2 sporadic AD, 3 wt Cortical neurons A β generation, localization, and oligomerization state, levels of cellular stress Kondo et al., 2013”
BackgroundSoldner, F., Laganière, J., Cheng, A. W., Hockemeyer, D., Gao, Q., Alagappan, R., Khurana, V., Golbe, L. I., Myers, R. H., Lindquist, S., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.019 · Cited by 728
Human ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage
Elkabetz, Y., Panagiotakos, G., Al Shamy, G., Socci, N. D., Tabar, V., & Studer, L. (2008) · Genes & Development · doi:10.1101/gad.1616208 · Cited by 677 · cited 3×
“Cell type References Forebrain neuronal precursors or neurons Chambers et al., 2009; Eiraku et al., 2008; Elkabetz et al., 2008; Emdad et al., 2012; Erceg et al., 2008; Espuny-Camacho et al., 2013; Gupta et al., 2011; Hu et al., 2010; Juopperi et al., 2012; Kirkeby et al., 2012; Lancaster et al.,…”
BackgroundTargeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients with a C9ORF72 Repeat Expansion
Sareen, D., O’Rourke, J. G., Meera, P., Muhammad, A. K. M. G., Grant, S., Simpkinson, M., Bell, S., Carmona, S., Ornelas, L., Sahabian, A., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007529 · Cited by 670
Kirkeby, A., Grealish, S., Wolf, D. A., Nelander, J., Wood, J., Lundblad, M., Lindvall, O., & Parmar, M. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.04.009 · Cited by 662 · cited 4×
“…et al., 2008; Emdad et al., 2012; Erceg et al., 2008; Espuny-Camacho et al., 2013; Gupta et al., 2011; Hu et al., 2010; Juopperi et al., 2012; Kirkeby et al., 2012; Lancaster et al., 2013; X. J. Li et al., 2009; Marchetto et al., 2010a; Mariani et al., 2012; Pankratz et al., 2007; Shi et…”
BackgroundInfluentialAn intrinsic mechanism of corticogenesis from embryonic stem cells
Gaspard, N., Bouschet, T., Hourez, R., Dimidschstein, J., Naeije, G., van den Ameele, J., Espuny-Camacho, I., Herpoel, A., Passante, L., Schiffmann, S. N., et al. (2008) · Nature · doi:10.1038/nature07287 · Cited by 641 · cited 1×
“…of neural progenitor cell proliferation, neuronal migration, and neurite outgrowth and arborization (Dhara & Stice, 2008; Eiraku et al., 2008; Gaspard et al., 2008; Krencik & Zhang, 2006; Lancaster et al., 2013; H. Liu & Zhang, 2011; Mariani et al., 2012; Maroof et al., 2013; Nicholas et…”
BackgroundModeling familial Alzheimer's disease with induced pluripotent stem cells
Yagi, T., Ito, D., Okada, Y., Akamatsu, W., Nihei, Y., Yoshizaki, T., Yamanaka, S., Okano, H., & Suzuki, N. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr394 · Cited by 599
Maroof, A. M., Keros, S., Tyson, J. A., Ying, S.-W., Ganat, Y. M., Merkle, F. T., Liu, B., Goulburn, A., Stanley, E. G., Elefanty, A. G., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.04.008 · Cited by 596
Wang, S., Bates, J., Li, X., Schanz, S., Chandler-Militello, D., Levine, C., Maherali, N., Studer, L., Hochedlinger, K., Windrem, M., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.12.002 · Cited by 586 · cited 5×
“…et al., 2011; Erceg et al., 2008; Kang et al., 2007; Krencik et al., 2011; Nistor et al., 2004; Ogawa et al., 2011; Swistowski et al., 2010; S. Wang et al., 2013; Wernig et al., 2008; S. C. Zhang et al., 2001 Neural crest precursors or derivatives (including peripheral neurons, nociceptors,…”
BackgroundInfluentialUsing iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome
Paşca, S. P., Portmann, T., Voineagu, I., Yazawa, M., Shcheglovitov, A., Paşca, A. M., Cord, B., Palmer, T. D., Chikahisa, S., Nishino, S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2576 · Cited by 585
Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome
Liu, G.-H., Barkho, B. Z., Ruiz, S., Diep, D., Qu, J., Yang, S.-L., Panopoulos, A. D., Suzuki, K., Kurian, L., Walsh, C., et al. (2011) · Nature · doi:10.1038/nature09879 · Cited by 575
Modeling human cortical development in vitro using induced pluripotent stem cells
Mariani, J., Simonini, M. V., Palejev, D., Tomasini, L., Coppola, G., Szekely, A. M., Horvath, T. L., & Vaccarino, F. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202944109 · Cited by 526 · cited 2×
“…et al., 2011; Hu et al., 2010; Juopperi et al., 2012; Kirkeby et al., 2012; Lancaster et al., 2013; X. J. Li et al., 2009; Marchetto et al., 2010a; Mariani et al., 2012; Pankratz et al., 2007; Shi et al., 2012; Sonntag et al., 2007; Wada et al., 2009; Wernig et al., 2008; Yuan et al., 2011; Zeng…”
BackgroundCooper, O., Seo, H., Andrabi, S., Guardia-Laguarta, C., Graziotto, J., Sundberg, M., McLean, J. R., Carrillo-Reid, L., Xie, Z., Osborn, T., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003985 · Cited by 508 · cited 1×
“…2 LRRK2 R1441C, 2 wt Neurons, dopaminergic neurons Response to stressors as measured by, mitochondrial respiration, proton leakage, mitochondrial mobility Cooper et al., 2012 2012 1 PARK2 homo ex2 – 4 del, 1 PARK2 homo ex6 – 7 del Dopaminergic neurons Oxidative stress, mitochondrial…”
MethodStructure-based redesign of the dimerization interface reduces the toxicity of zinc-finger nucleases
Szczepek, M., Brondani, V., Büchel, J., Serrano, L., Segal, D. J., & Cathomen, T. (2007) · Nature Biotechnology · doi:10.1038/nbt1317 · Cited by 501 · cited 1×
“Other FokI mutations have been engineered to reduce toxicity, enhance nuclease activity, or restrict activity to singlestranded cutting ( “ nickases ” ) (Guo et al., 2010; E. Kim et al., 2012; Ramirez et al., 2012; Szczepek et al., 2007; J. Wang et al., 2012).”
BackgroundParkinson’s disease induced pluripotent stem cells with triplication of the α-synuclein locus
Devine, M. J., Ryten, M., Vodicka, P., Thomson, A. J., Burdon, T., Houlden, H., Cavaleri, F., Nagano, M., Drummond, N. J., Taanman, J.-W., et al. (2011) · Nature Communications · doi:10.1038/ncomms1453 · Cited by 486 · cited 1×
“…neurons ND Soldner et al., 2011 2011 1 SCNA triplication, 1 wt Dopaminergic neurons Expression of α -synuclein and other triplicated genes Devine et al., 2011 2011 1 SCNA triplication, 1 wt Dopaminergic neurons α -Synuclein expression, oxidative stress, peroxideinduced cell death…”
BackgroundMarchetto, M. C. N., Muotri, A. R., Mu, Y., Smith, A. M., Cezar, G. G., & Gage, F. H. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.10.001 · Cited by 475 · cited 2×
“Non-cell autonomous effects have been carefully studied in models of ALS, which have revealed cytotoxicity of SOD1 -mutant astrocytes on motor neurons (Di Giorgio et al., 2007, 2008; Marchetto et al., 2008).”
BackgroundSHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients
Shcheglovitov, A., Shcheglovitova, O., Yazawa, M., Portmann, T., Shu, R., Sebastiano, V., Krawisz, A., Froehlich, W., Bernstein, J. A., Hallmayer, J. F., et al. (2013) · Nature · doi:10.1038/nature12618 · Cited by 470
Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells
Buchholz, D. E., Hikita, S. T., Rowland, T. J., Friedrich, A. M., Hinman, C. R., Johnson, L. V., & Clegg, D. O. (2009) · Stem Cells · doi:10.1002/stem.189 · Cited by 417 · cited 1×
“…Mica et al., 2013; Pomp et al., 2005; Valensi-Kurtz et al., 2010; Ziegler et al., 2010 Cranial placode derivatives Dincer et al., 2013 Retinal cells Buchholz et al., 2009; Hirami et al., 2009; Jin et al., 2011; Kokkinaki et al., 2011; Lamba et al., 2006; Meyer et al., 2009; 2011; Nakano et al.,…”
BackgroundEnhancing zinc-finger-nuclease activity with improved obligate heterodimeric architectures
Doyon, Y., Vo, T. D., Mendel, M. C., Greenberg, S. G., Wang, J., Xia, D. F., Miller, J. C., Urnov, F. D., Gregory, P. D., & Holmes, M. C. (2011) · Nature Methods · doi:10.1038/nmeth.1539 · Cited by 402
Progressive degeneration of human neural stem cells caused by pathogenic LRRK2
Liu, G.-H., Qu, J., Suzuki, K., Nivet, E., Li, M., Montserrat, N., Yi, F., Xu, X., Ruiz, S., Zhang, W., et al. (2012) · Nature · doi:10.1038/nature11557 · Cited by 339
Bilican, B., Serio, A., Barmada, S. J., Nishimura, A. L., Sullivan, G. J., Carrasco, M., Phatnani, H. P., Puddifoot, C. A., Story, D., Fletcher, J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202922109 · Cited by 328
Almeida, S., Gascon, E., Tran, H., Chou, H. J., Gendron, T. F., DeGroot, S., Tapper, A. R., Sellier, C., Charlet-Berguerand, N., Karydas, A., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1149-y · Cited by 321
Chamberlain, S. J., Chen, P.-F., Ng, K. Y., Bourgois-Rocha, F., Lemtiri-Chlieh, F., Levine, E. S., & Lalande, M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004487107 · Cited by 312 · cited 1×
“…“ memory ” can impact the study of certain disease loci, which may remain silenced after reprogramming (Amenduni et al., 2011; Ananiev et al., 2011; Chamberlain et al., 2010; Cheung et al., 2011; Farra et al., 2012; K.-Y. Kim et al., 2011; Larimore et al., 2013; J. Liu et al., 2012c; Mekhoubad…”
BackgroundDifferentiation of spinal motor neurons from pluripotent human stem cells
Hu, B.-Y., & Zhang, S.-C. (2009) · Nature Protocols · doi:10.1038/nprot.2009.127 · Cited by 298 · cited 1×
“…2009 Motor neuron precursors or neurons Chambers et al., 2009; Elkabetz et al., 2008; Erceg et al., 2008; Hester et al., 2011; Hu et al., 2010; Hu & Zhang, 2009; H. Lee et al., 2007b; X.-J. Li et al., 2005; 2008; Nizzardo et al., 2010; Roy et al., 2005; Wada et al., 2009; Zeng et al., 2010…”
Cheung, A. Y. L., Horvath, L. M., Grafodatskaya, D., Pasceri, P., Weksberg, R., Hotta, A., Carrel, L., & Ellis, J. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr093 · Cited by 271 · cited 2×
“…the study of certain disease loci, which may remain silenced after reprogramming (Amenduni et al., 2011; Ananiev et al., 2011; Chamberlain et al., 2010; Cheung et al., 2011; Farra et al., 2012; K.-Y. Kim et al., 2011; Larimore et al., 2013; J. Liu et al., 2012c; Mekhoubad et al., 2012; Urbach et…”
BackgroundMolecular aging in human prefrontal cortex is selective and continuous throughout adult life
Erraji-Benchekroun, L., Underwood, M. D., Arango, V., Galfalvy, H., Pavlidis, P., Smyrniotopoulos, P., Mann, J. J., & Sibille, E. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.034 · Cited by 236
Guo, J., Gaj, T., & Barbas, C. F. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.04.060 · Cited by 206
Hester, M. E., Murtha, M. J., Song, S., Rao, M., Miranda, C. J., Meyer, K., Tian, J., Boulting, G., Schaffer, D. V., Zhu, M. X., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.135 · Cited by 183
Pluripotent stem cells in neurodegenerative and neurodevelopmental diseases
Marchetto, M. C. N., Winner, B., & Gage, F. H. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq159 · Cited by 152
Almeida, S., Zhang, Z., Coppola, G., Mao, W., Futai, K., Karydas, A., Geschwind, M. D., Tartaglia, M. C., Gao, F., Gianni, D., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.09.007 · Cited by 140
Fong, H., Wang, C., Knoferle, J., Walker, D., Balestra, M. E., Tong, L. M., Leung, L., Ring, K. L., Seeley, W. W., Karydas, A., et al. (2013) · Stem Cell Reports · doi:10.1016/j.stemcr.2013.08.001 · Cited by 122
Variability in the generation of induced pluripotent stem cells: Importance for disease modeling
Vitale, A. M., Matigian, N. A., Ravishankar, S., Bellette, B., Wood, S. A., Wolvetang, E. J., & Mackay-Sim, A. (2012) · Stem Cells Translational Medicine · doi:10.5966/sctm.2012-0043 · Cited by 79 · cited 2×
“…Hester et al., 2011; Hu et al., 2010; Hu & Zhang, 2009; H. Lee et al., 2007b; X.-J. Li et al., 2005; 2008; Nizzardo et al., 2010; Roy et al., 2005; Wada et al., 2009; Zeng et al., 2010 Dopaminergic neurons Chambers et al., 2009; Cho et al., 2008a; Cho et al., 2008b; Cooper et al., 2010; Elkabetz…”
Cited by
Centeno, E. G. Z., Cimarosti, H., & Bithell, A. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0258-4 · Cited by 268
Wu, S., Xu, R., Duan, B., & Jiang, P. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb00721c · Cited by 111
Back and forth in time: Directing age in iPSC-derived lineages
Cornacchia, D., & Studer, L. (2017) · Brain Research · doi:10.1016/j.brainres.2015.11.013 · Cited by 56
Metadata
- Authors
- Srikanth, P., & Young-Pearse, T. L.
- Venue
- Journal of Neurogenetics
- Publisher
- Informa UK Limited
- Published
- 2014-03-17
- Volume
- 28
- Issue
- 1-2
- Pages
- 5-29
- ISSN
- 0167-7063 (ISSN-L)
- 1563-5260
- OpenAlex
- W2055002688
- Cited by
- 57
- References
- 60
- FWCI
- 4.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.